C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus

Mahajan, Supriya D., Parikh, Neil U., Woodruff, Trent M., Jarvis, James N., Lopez, Molly, Hennon, Teresa, Cunningham, Patrick, Quigg, Richard J., Schwartz, Stanley A. and Alexander, Jessy J. (2015) C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology, 146 1: 130-143. doi:10.1111/imm.12489

Author Mahajan, Supriya D.
Parikh, Neil U.
Woodruff, Trent M.
Jarvis, James N.
Lopez, Molly
Hennon, Teresa
Cunningham, Patrick
Quigg, Richard J.
Schwartz, Stanley A.
Alexander, Jessy J.
Title C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus
Formatted title
C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus
Journal name Immunology   Check publisher's open access policy
ISSN 1365-2567
Publication date 2015-09
Sub-type Article (original research)
DOI 10.1111/imm.12489
Open Access Status Not yet assessed
Volume 146
Issue 1
Start page 130
End page 143
Total pages 14
Place of publication Chichester, West Sussex,United Kingdom
Publisher Wiley-Blackwell Publishing
Collection year 2016
Language eng
Formatted abstract
The blood–brain barrier (BBB) plays a crucial role in brain homeostasis, thereby maintaining the brain environment precise for optimal neuronal function. Its dysfunction is an intriguing complication of systemic lupus erythematosus (SLE). SLE is a systemic autoimmune disorder where neurological complications occur in 5–50% of cases and is associated with impaired BBB integrity. Complement activation occurs in SLE and is an important part of the clinical profile. Our earlier studies demonstrated that C5a generated by complement activation caused the loss of brain endothelial layer integrity in rodents. The goal of the current study was to determine the translational potential of these studies to a human system. To assess this, we used a two dimensional in vitro BBB model constructed using primary human brain microvascular endothelial cells and astroglial cells, which closely emulates the in vivo BBB allowing the assessment of BBB integrity. Increased permeability monitored by changes in transendothelial electrical resistance and cytoskeletal remodelling caused by actin fiber rearrangement were observed when the cells were exposed to lupus serum and C5a, similar to the observations in mice. In addition, our data show that C5a/C5aR1 signalling alters nuclear factor-κB translocation into nucleus and regulates the expression of the tight junction proteins, claudin-5 and zonula occludens 1 in this setting. Our results demonstrate for the first time that C5a regulates BBB integrity in a neuroinflammatory setting where it affects both endothelial and astroglial cells. In addition, we also demonstrate that our previous findings in a mouse model, were emulated in human cells in vitro, bringing the studies one step closer to understanding the translational potential of C5a/C5aR1 blockade as a promising therapeutic strategy in SLE and other neurodegenerative diseases.
Keyword Anaphylatoxins
Blood-brain barrier
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2016 Collection
School of Biomedical Sciences Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 18 Aug 2015, 01:43:02 EST by System User on behalf of Scholarly Communication and Digitisation Service